FindTrial
Sign In

Effects of L-carnitine Treatment on Cardiac Function in Maintenance Hemodialysis Patients: A Multicenter, Prospective, Non-randomized Controlled Real-world Study

Effects of L-carnitine Treatment on Cardiac Function in Maintenance Hemodialysis Patients: A Multicenter, Prospective, Non-randomized Controlled Real-world Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109719
Enrollment
Unknown
Registered
2025-09-24
Start date
2023-06-08
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maintenance hemodialysis

Interventions

experimental group:Intravenous injection of levocarnitine
control group:No treatment with levocarnitine

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1,Maintenance hemodialysis patients, 2,Age between 18 and 80 years 3,Clear consciousness and ability to act independently

Exclusion criteria

Exclusion criteria: 1,History of epilepsy, 2,Acute cardiovascular or cerebrovascular events within the past month 3,Concurrent hematological disorders or solid tumors

Design outcomes

Primary

MeasureTime frame
left ventricular ejection fraction;LVSF;—

Secondary

MeasureTime frame
serum albumin;prealbumin;electrolyte;BNP;cardiac troponin;Blood creatinine;urea nitrogen;—

Countries

China

Contacts

Public ContactHongbo.Chen

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)

Chenhb521@126.com+86 138 5808 9008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026